1. |
Shimada M, Itamochi H, Kigawa J. Nedaplatin: a cisplatin derivative in cancer chemotherapy. Cancer Manag Res, 2013, 5(default): 67-76.
|
2. |
Kodama J, Takemoto M, Seki N, et al. Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer. Int J Gynecol Cancer, 2008, 18(5): 1037-1041.
|
3. |
Niibe Y, Tsunoda S, Jobo T, et al. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)-initial analysis. Eur J Gynaecol Oncol, 2008, 29(3): 222-224.
|
4. |
Yuan G, Wu L, Huang M, et al. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix. Radiat Oncol, 2014, 9(default): 55.
|
5. |
Kobayashi Y, Ohara T, Wada Y, et al. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer. J Obstet Gynaecol Res, 2009, 35(3): 490-494.
|
6. |
周晖, 卢淮武, 彭永排, 等. 《2015年NCCN宫颈癌临床实践指南》解读. 中国实用妇科与产科杂志, 2015, 30(3): 185-191.
|
7. |
Takeshita S, Kita T, Motoike Y, et al. Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer. J Obstet Gynaecol Res, 2010, 36(5): 1009-1014.
|
8. |
Colombo N, Carinelli S, Colombo A, et al. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012, 23 Suppl 7(suppl_5): vii27.
|
9. |
郑建清, 黄碧芬. 宫颈癌术后紫杉醇联合顺铂同步放化疗的临床研究. 中国实用医药, 2015, 10(1): 11-13.
|
10. |
叶伟军, 徐敏, 曹新平, 等. 奈达铂同期放化疗治疗中晚期宫颈癌前瞻性临床研究. 国际肿瘤学杂志, 2014, 41(6): 476-479.
|
11. |
Kagabu M, Shoji T, Murakami K, et al. Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study. Int J Clin Oncol, 2016, 21(4): 735-740.
|
12. |
Mabuchi S, Morishige K, Isohashi F, et al. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol, 2009, 115(3): 482-487.
|
13. |
Isohashi F, Mabuchi S, Yoshioka Y, et al. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters. Radiat Oncol, 2015, 10(default): 180.
|
14. |
谢忆山, 唐甜, 李长虎, 等. 宫颈癌术后奈达铂同步调强放疗的临床研究. 安徽医学, 2013, 34(12): 1813-1815.
|